Differences

This shows you the differences between two versions of the page.

--- beate_sander [2022/03/11 03:21]
liam
+++ beate_sander [2024/12/29 01:14] (current)
liam
@@ Line 28: / Line 28: @@
 ==== National Advisory Committee on Immunization ====
-Sander is a member of the [[National Advisory Committee on Immunization]] (NACI), where she also chairs the Economics Task Group and co-chairs the Economic Guidelines Task Group.
+Sander is a member of the [[National Advisory Committee on Immunization]] (NACI), where she also chairs the Economics Task Group and co-chairs the Economic Guidelines Task Group. She receives reimbursement to attend NACI meetings, and acknowledges this role presents a conflict of interest with her work on the OST (including regarding [[COVID-19 vaccines]]).((Sander, B. (2020). //Declaration of Interest.// Ontario COVID-19 Science Advisory Table. https://web.archive.org/web/20220108230014/https://covid19-sciencetable.ca/wp-content/uploads/2020/07/Declaration-of-Interest_Science-Table_Beate-Sander.pdf))
 ==== Society for Medical Decision Making ====
@@ Line 50: / Line 49: @@
 Sander is a Scientific Co-Chair of the [[Canadian Lyme Disease Research Network]], a project lead by [[public_health_agencies:canada:public_health_ontario:Kieran Moore]], Chief Medical Officer of Health (CMOH) for [[public_health_agencies:Public Health Ontario]].((//Meet The Team.// Canadian Lyme Disease Research Network. Retrieved March 10, 2022, from https://archive.ph/KNI39)) The project is funded through the [[Canadian Institute for Health Information]] (CIHI), and Sander is a co-applicant on the grant.((Moore, K. (2019, July 29). //Disclosure of Conflict of Interest.// Canadian Lyme Disease Research Network. Retrieved November 24, 2021, from https://www.clydrn.ca/wp-content/uploads/2019/07/Moore-Kieran.pdf)) ((Canadian Lyme Disease Research Network. //Kieran Moore Bio.// Retrieved November 24, 2021, from https://www.clydrn.ca/the-team-kieran-moore/)) She reported no conflicts of interest in a July 9, 2019 disclosure.((Sander, B. (2019). //Disclosure of Conflict of Interest Definitions.// Canadian Lyme Disease Research Network. https://web.archive.org/web/20210509002642/https://www.clydrn.ca/wp-content/uploads/2019/07/Sander-Beate.pdf))
+==== York University ====
+Sander is an Adjunct Faculty member in the Department of Mathematics and Statistics at [[York University]], and a member of the [[LAboratory of Mathematical Parallel Systems]] laboratory.((//Members of LAMPS.// LAboratory of Mathematical Parallel Systems. Retrieved March 11, 2022, from https://archive.ph/hWNyW)) ((//Beate Sander.// UHN Research. Retrieved March 10, 2022, from https://www.uhnresearch.ca/researcher/beate-sander))
 ==== Institute for Clinical Evaluative Sciences (2012-current) ====
@@ Line 90: / Line 93: @@
     * Funded through ICES by the [[Canadian Institutes of Health Research]] for a total of $409,276.00.
+She has also received funding from the [[Canadian Immunization Research Network]], [[Ontario Health]], the [[public_health_agencies:Canada:Public Health Agency of Canada]] and the [[World Health Organization]].((Sander, B. (2020). //Declaration of Interest.// Ontario COVID-19 Science Advisory Table. https://web.archive.org/web/20220108230014/https://covid19-sciencetable.ca/wp-content/uploads/2020/07/Declaration-of-Interest_Science-Table_Beate-Sander.pdf)) ((Sander, B. (2021). //Declaration of Interest.// Ontario COVID-19 Science Advisory Table. https://web.archive.org/web/20220309073247/https://covid19-sciencetable.ca/wp-content/uploads/2020/07/Declaration-of-Interest_Science-Table_Beate-Sander-1.pdf))
+==== COVID-19 ====
+Beate received funding from the Ontario COVID-19 Rapid Research Fund as principal investigator for an "Ontario Together" study titled "Ontario’s Response to COVID-19: Balancing Trade-offs and Improving Outcomes for all Ontarians".((//Ontario COVID-19 Rapid Research Fund.// Government of Ontario. Retrieved March 10, 2022, from https://archive.ph/I2enS))
+The CIHR provided her a grant as Co-Investigator for "Scalable, Customizable, Digital Health Communication Materials to Help Canada Address the COVID-19 Pandemic" at Witteman Lab.((Parent, E. //Scalable, Customizable, Digital Health Communication Materials to Help Canada Address the COVID19 Pandemic.// Witteman Lab. Retrieved March 10, 2022, from https://archive.ph/pVPDW))
+Beate received a grant from the [[Canadian Cardiovascular Society]]'s COVID-19 Challenge for Canada Initiative for a study titled "Co-Investigator Consequences of delays in cardiac procedures and surgeries due to the COVID-19 pandemic". Additional funding came from the [[Heart and Stroke Foundation of Canada]] and ICES.((Tam, D. Y., Qiu, F., Manoragavan, R., Fremes, S. E., Hassan, A., Ko, D. T., Lauck, S. B., Naimark, D., Ouzounian, M., Sander, B., Sun, L., & Wijeysundera, H. C. (2021). //The Impact of the COVID-19 Pandemic on Cardiac Procedure Wait List Mortality in Ontario, Canada.// Canadian Journal of Cardiology, 37(10), 1547–1554. https://doi.org/10.1016/j.cjca.2021.05.008))
 ===== Awards and Recognition =====
@@ Line 107: / Line 118: @@
 Sander was interviewed in December 2021 for the [[Toronto Star]] on the subject of the [[sars-cov-2:Omicron]] variant.((Arthur, B. (2021, December 10). //Opinion | It’s hard to look this in the eye. But COVID’s worst is coming.// The Toronto Star. https://archive.ph/nHfPM))
-===== Public Contact Information =====
+===== External links =====
-Sander can be reached by phone at 647-260-7425.
+  * [[https://wiki.whiteroseintelligence.com/en/Beate-Sander|White Rose Wiki]]